Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Improving uptake of colorectal cancer screening

   4631

The Lancet Gastroenterology & Hepatology - Colorectal cancer is the third most common cancer worldwide, and the second most lethal. Screening reduces colorectal cancer mortality, and many countries have implemented screening programmes.

Nevertheless, the effectiveness of colorectal cancer screening is reduced by lack of uptake and less than optimal adherence to follow-up guidelines.

Screening uptake varies substantially by ethnicity, income, and educational status; reaching disengaged groups is a more challenging task, and it is clear that no single form of outreach to facilitate education about and promotion of colorectal cancer screening programmes will achieve high participation rates.

This study underlines that collaboration between health-care providers and policy makers is needed to define and implement combinations of effective interventions, tailored to specific population needs, to prevent further avoidable deaths from colorectal cancer.

 

Improving uptake of colorectal cancer screening

 

The Lancet Gastroenterology & Hepatology - DOI: http://dx.doi.org/10.1016/S2468-1253(17)30298-4 - Editoriale novembre 2017

Improving uptake of colorectal cancer screening

Click here to read the full article 


Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×